APA Citatie

Camporeale, A., Kudrow, D., Sides, R., Wang, S., Van Dycke, A., Selzler, K. J., & Stauffer, V. L. (2018). A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine. BMC Neurol.

Chicago Style citaat

Camporeale, Angelo, David Kudrow, Ryan Sides, Shufang Wang, Annelies Van Dycke, Katherine J. Selzler, en Virginia L. Stauffer. "A Phase 3, Long-term, Open-label Safety Study of Galcanezumab in Patients With Migraine." BMC Neurol 2018.

MLA citatie

Camporeale, Angelo, et al. "A Phase 3, Long-term, Open-label Safety Study of Galcanezumab in Patients With Migraine." BMC Neurol 2018.